Skip to main content
. 2013 May 18;10(3):486–497. doi: 10.1007/s13311-013-0194-5

Fig. 1.

Fig. 1

Antisense oligonucleotide (ASO) chemical structures. Schematic of unmodified DNA/RNA base pair (left). Different backbone modifications that can be applied (top row) and different 2’-sugar modifications that can be used (bottom row) to increase nuclease resistance and RNA binding affinity of the ASO. Deviations from the original unmodified DNA/RNA are highlighted by circles